Skip to main content
. 2024 Oct 25;14:25427. doi: 10.1038/s41598-024-76330-z

Table 1.

Differences in characteristics between the training cohort and the validation cohort.

Variables Total cohort
(n = 236)
Training cohort (n = 165) Validation cohort
(n = 71)
P value
Educationalbackground (%) 0.728
 Unschooled 1(0.42) 1(0.61) 0(0.00)
 Primary school degree 6(2.54) 3(1.82) 3(4.23)
 Junior high school degree 25(10.59) 19(11.52) 6(8.45)
 Senior high school degree 51(21.61) 36(21.82) 15(21.13)
 University degree degree 153(64.83) 106(64.24) 47(66.20)
Married (%) 0.610
 No 122(51.69) 83(50.30) 39(54.93)
 Yes 114(48.31) 82(49.70) 32(45.07)
Age, mean (SD), year 28.98(7.69) 28.98(7.56) 29.00(8.06) 0.982
Genders (%) 0.576
 Female 155(65.68) 106(64.24) 49 (69.01)
 Male 81(34.32) 59(35.76) 22(30.99)
Height, mean (SD), cm 167.42(8.41) 167.40(8.02) 167.46(9.32) 0.962
Weight, mean (SD), cm 110.27(27.72) 111.07(27.67) 108.39(28.01) 0.498
BMI, mean (SD), kg/m2 38.93(7.52) 39.25(7.64) 38.21(7.24) 0.332
BMI classification (%) 0.887
 0(25.0-29.9) 16(6.78) 11(6.67) 5(7.04)
 1(30.0-34.9) 55(23.31) 39(23.64) 16(22.54)
 2(35.0-39.9) 75(31.78) 50(30.30) 25(35.21)
 3(≥ 40) 90(38.14) 65(39.39) 25(35.21)
Depression (%) 0.557
 No 227(96.19) 160(96.97) 67(94.37)
 Yes 9(3.81) 5(3.03) 4(5.63)
Antidepressant treatment (%) 0.742
 No 229(97.03) 161(97.58) 68(95.77)
 Yes 7(2.97) 4(2.42) 3(4.23)
Hypertension (%) 0.961
 No 184(77.97) 128(77.58) 56(78.87)
 Yes 52(22.03) 37(22.42) 15(21.13)
Hepatitis B (%) 0.371
 No 227(96.19) 157(95.15) 70(98.59)
 Yes 9(3.81) 8(4.85) 1(1.41)
Diabetes (%) 0.560
 No 189(80.08) 130(78.79) 59(83.10)
 Yes 47(19.92) 35(21.21) 12(16.90)
Hypertriglyceridemia (%) 0.956
 No 112(47.46) 79(47.88) 33(46.48)
 Yes 124(52.54) 86(52.12) 38(53.52)
Nonalcoholic Fatty Liver Disease (%) 0.458
 No 16(6.78) 13(7.88) 3(4.23)
 Yes 220(93.22) 152(92.12) 68(95.77)
Obstructive sleep apnea hypopnea syndrome (%) 0.086
 No 196(93.05) 132(80.00) 64(90.14)
 Yes 40(16.95) 33(20.00) 7(9.86)
Gastroesophageal reflux disease (%) 0.510
 No 200(84.75) 142(86.06) 58(81.69)
 Yes 36(15.25) 142(86.06) 58(81.69)
Hiatal hernia (%) 0.806
 No 216(91.53) 152(92.12) 64(90.14)
 Yes 20(8.47) 13(7.88) 7(9.86)
Helicobacter pylori (%) 0.120
 No 192(81.36) 139(84.24) 53(74.65)
 Yes 44(18.64) 26(15.76) 18(25.35)
Pepticuler (%) 0.910
 No 217(91.95) 151(91.52) 66(92.96)
 Yes 19(8.05) 14(8.48) 5(7.04)
Gastric ulcer (%) 0.898
 No 225(95.34) 158(95.76) 67(94.37)
 Yes 11(4.66) 7(4.24) 4(5.63)
Duodenal ulcers (%) 0.477
 No 228(96.61) 158(95.76) 70(98.59)
 Yes 8(3.39) 7(4.24) 1(1.41)
Gallbladder stones (%) 1.000
 No 217(91.95) 152(92.12) 65(91.55)
 Yes 19(8.05) 13(7.88) 6(8.45)
Gallbladder polyp (%) 0.612
 No 229 (97.03) 159 (96.36) 70(98.59)
 Yes 7(2.97) 6(3.64) 1(1.41)
Smoking (%) 0.198
 No 198(83.90) 138(83.64) 60(84.51)
 Yes 38(16.10) 27(16.36) 11(15.49)
Drinking (%) 1.000
 No 225(95.34) 157(95.15) 68(95.77)
 Yes 11(4.66) 8(4.85) 3(4.23)
History of abdominalsurgery (%) 0.255
 No 173(73.31) 125(75.76) 48(67.61)
 Yes 63(26.69) 40(24.24) 23(32.39)
White blood cell, mean (SD), 109/L 8.38(2.04) 8.39(2.05) 8.34(2.05) 0.865
Lymphocyte, mean (SD), 109/L 2.74(1.62) 2.76(1.87) 2.68(0.79) 0.703
Neutrophilic granulocyte, mean (SD), 109/L 5.11(1.66) 5.12(1.71) 5.09(1.54) 0.870
Hemoglobin, mean (SD), g/L 142.68(16.54) 142.70(16.29) 142.63(17.22) 0.977
Platelet, mean (SD), 109/L 295.01(209.17) 299.05(246.70) 285.63(64.56) 0.652
Fasting insulin, mean (SD), µ IU/mL 37.78(30.35) 36.70(25.11) 40.27(40.06) 0.409
Fasting c-peptide, mean (SD), ng/ml 4.56(2.26) 4.47(2.19) 4.76(2.42) 0.362
Total protein, mean (SD), g/L 74.37(5.24) 74.02(5.59) 75.17(4.26) 0.125
Albumin, mean (SD), g/L 43.18(3.43) 43.00(3.51) 43.59(3.21) 0.228
Alanine aminotransferase, mean (SD), U/L 59.20(49.07) 57.80(50.08) 62.45(46.84) 0.516
Aspartate aminotransferase, mean (SD), U/L 38.04(28.22) 37.02(27.37) 40.42(33.17) 0.397
Gamma-glutamyl transpeptidase, mean (SD), U/L 49.85(33.14) 49.89(33.37) 49.76(32.82) 0.978
Alkaline phosphatase, mean (SD), U/L 82.86(25.89) 84.07(26.38) 80.07(24.67) 0.278
Fasting plasma glucose, mean (SD), mmol/L 5.81(2.11) 5.88(2.19) 5.65(1.93) 0.451
Total serum bilirubin, mean (SD), µmol/L 12.65(5.48) 12.45(5.42) 13.11(5.62) 0.393
Direct Bilirubin, mean (SD), µmol/L 2.57(1.75) 2.48(1.52) 2.79(2.18) 0.209
Total bile acid, mean (SD), µmol/L 4.75(7.82) 4.33(3.32) 5.74(13.35) 0.206
Creatinine, mean (SD), µmol/L 71.65(32.11) 72.67(37.04) 69.29(15.40) 0.459
Uric Acid, mean (SD) ,µmol/L 427.91(96.60) 426.59(95.35) 430.96(100.05) 0.751
Total cholesterol, mean (SD), mmol/L 7.61(37.30) 8.65(44.61) 5.20(1.12) 0.515
Triglyceride, mean (SD), mmol/L 2.04(1.57) 2.13(1.73) 1.84(1.12) 0.209
High density lipoprotein, mean (SD), mmol/L 1.13(0.26) 1.12(0.26) 1.15(0.25) 0.418
Low density lipoprotein, mean (SD), mmol/L 3.23(0.85) 3.22(0.82) 3.25(0.92) 0.839
Hemoglobin A1, mean (SD),% 8.31(1.52) 8.35(1.51) 8.22(1.54) 0.551
Hemoglobin A1C, mean (SD),% 6.02(1.23) 6.06(1.20) 5.93(1.29) 0.465
Prothrombin time, mean (SD), s 11.11(0.67) 11.10(0.68) 11.14(0.64) 0.724
Symptoms worsen
 No 152(64.41) 102(70.42) 50(70.42) 0.264
 Yes 84(35.59) 63(38.18) 21(29.58)